Blockade of β-cell KATP channels by the endocannabinoid, 2-arachidonoylglycerol

Biochemical and Biophysical Research Communications

Volumn 423, Issue 1, 2012, Pages 13-18

  Spivak, Charles E ^a   Kim, Wook ^b   Liu, Qing Rong ^a   Lupica, Carl R ^a   Doyle, Máire E ^c  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cell; Endocannabinoid; Insulinoma cell line; Low glucose; Receptor independent effects

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL L TYPE; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; GLUCOSE; POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; IC 50; INSULIN RELEASE; INSULINOMA; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN INTERACTION;

ANIMALS; ARACHIDONIC ACIDS; CALCIUM; CANNABINOID RECEPTOR MODULATORS; CELL LINE, TUMOR; ENDOCANNABINOIDS; GLUCOSE; GLYCERIDES; INSULIN; INSULIN-SECRETING CELLS; KATP CHANNELS; MICE; PATCH-CLAMP TECHNIQUES; RECEPTOR, CANNABINOID, CB1;

EID: 84862697350     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.042     Document Type: Article

References (22)

1. Piomelli D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 2003, 4:873-884.
2. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002, 54:161-202.
3. Di Marzo V., Bifulco M., De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat. Rev. Drug Discovery 2004, 3:771-784.
4. Kim W., Doyle M.E., Liu Z., Lao Q., Shin Y.K., Carlson O.D., Kim H.S., Thomas S., Napora J.K., Lee E.K., Moaddel R., Wang Y., Maudsley S., Martin B., Kulkarni R.N., Egan J.M. Cannabinoids inhibit insulin receptor signaling in pancreatic {beta}-cells. Diabetes 2011, 60:1198-1209.
5. Bermudez-Silva F.J., Suarez Perez J., Nadal A., Rodriguez de Fonseca F. The role of the pancreatic endocannabinoid system in glucose metabolism. Best Pract. Res. Clin. Endocrinol. Metab. 2009, 23:87-102.
6. Oz M. Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids. Pharmacol. Ther. 2006, 111:114-144.
7. Li C., Bowe J.E., Huang G.C., Amiel S.A., Jones P.M., Persaud S.J. Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans. Diabetes Obes. Metab. 2011, 13:903-910.
8. Li C., Bowe J.E., Jones P.M., Persaud S.J. Expression and function of cannabinoid receptors in mouse islets. Islets 2010, 2:293-302.
9. Glasbey C.A., Martin R.J. The distribution of numbers of open channels in multi-channel patches. J. Neurosci. Methods 1988, 24:283-287.
10. Laaris N., Good C.H., Lupica C.R. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus. Neuropharmacology 2010, 59:121-127.
11. D'Ambra T.E., Estep K.G., Bell M.R., Eissenstat M.A., Josef K.A., Ward S.J., Haycock D.A., Baizman E.R., Casiano F.M., Beglin N.C. Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor. J. Med. Chem. 1992, 35:124-135.
12. Ashcroft F.M. Adenosine 5'-triphosphate-sensitive potassium channels. Annu. Rev. Neurosci. 1988, 11:97-118.
13. Lan R., Liu Q., Fan P., Lin S., Fernando S.R., McCallion D., Pertwee R., Makriyannis A. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J. Med. Chem. 1999, 42:769-776.
14. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 1995, 50:83-90.
15. MacDonald P.E., Wheeler M.B. Voltage-dependent K(+) channels in pancreatic beta cells: role, regulation and potential as therapeutic targets. Diabetologia 2003, 46:1046-1062.
16. Jacobson D.A., Weber C.R., Bao S., Turk J., Philipson L.H. Modulation of the pancreatic islet beta-cell-delayed rectifier potassium channel Kv2.1 by the polyunsaturated fatty acid arachidonate. J. Biol. Chem. 2007, 282:7442-7449.
17. Moreno-Galindo E.G., Barrio-Echavarria G.F., Vasquez J.C., Decher N., Sachse F.B., Tristani-Firouzi M., Sanchez-Chapula J.A., Navarro-Polanco R.A. Molecular basis for a high-potency open-channel block of Kv1.5 channel by the endocannabinoid anandamide. Mol. Pharmacol. 2010, 77:751-758.
18. + channels. Neuropharmacology 1996, 35:983-991.
19. Oz M., Tchugunova Y., Dinc M. Differential effects of endogenous and synthetic cannabinoids on voltage-dependent calcium fluxes in rabbit T-tubule membranes: comparison with fatty acids. Eur. J. Pharmacol. 2004, 502:47-58.
20. Johnson D.E., Heald S.L., Dally R.D., Janis R.A. Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine binding. Prostaglandins Leukot. Essent. Fatty Acids 1993, 48:429-437.
21. 2+ channel. Eur. J. Pharmacol. 1996, 296:347-350.
22. Li C., Jones P.M., Persaud S.J. Cannabinoid receptors are coupled to stimulation of insulin secretion from mouse MIN6 beta-cells. Cell. Physiol. Biochem. 2010, 26:187-196.